Carle Cancer Institute Normal is a clinical research site located in Normal, Illinois, United States 61761.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Carle Cancer Institute Normal has participated in 103 clinical trials with 81 currently active.
Therapeutic areas: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.
Sponsors: National Cancer Institute (NCI), Wake Forest University Health Sciences, GOG Foundation.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Normal
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Carle Cancer Institute Normal has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Carle Cancer Institute Normal has 103 clinical trials on record, with 81 currently active. Their work covers Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.
Carle Cancer Institute Normal has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.